Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Introduction: Secondary central nervous system lymphoma (SCNSL) is a rare and aggressive subtype of non-Hodgkin lymphoma that involves the neuraxis. Patients with refractory or relapsed (r/r) disease have limited treatment options and poor outcomes. Chimeric antigen receptor T-cell therapy (CAR T) has shown promise in clinical trials but lacks mature data in the r/r SCNSL setting.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
